Drugs / CircFam53B-219aa DC vaccine
last change Apr 2026 re-read 2 minutes ago

CircFam53B-219aa DC vaccine

Vaccine

Developed for
breast cancer
Investigated by
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Trials 1 · a red edge is where a trial was stopped

20252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT06530082 Dec 2024 → Apr 2026 overdue breast cancer Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Not yet recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CircFam53B-219aa DC vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT06530082
Modality Vaccine “Dendritic cell vaccine loaded with circular RNA-encoded cryptic peptide.” NCT06530082